Nicotine potentiation of brain stimulation reward reversed by DHβE and SCH 23390, but not by eticlopride, LY 314582 or MPEP in rats

Psychopharmacology

Volumn 160, Issue 1, 2002, Pages 56-66

  Harrison, Amanda A ^a,c   Gasparini, Fabrizio ^b,c   Markou, Athina ^a,c  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

^c UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Brain stimulation reward; DH E; Dopamine; Eticlopride; Glutamate; LY 314582; MPEP; Nicotine; Rat; SCH 23390

Indexed keywords

2 METHYL 6 (PHENYLETHYNYL)PYRIDINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; CHOLINERGIC RECEPTOR; DIHYDRO BETA ERYTHROIDINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; ETICLOPRIDE; LY 314582; METABOTROPIC RECEPTOR; METABOTROPIC RECEPTOR AGONIST; NICOTINE; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ARTICLE; BRAIN DEPTH STIMULATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ELECTRODE; ELECTROSTIMULATION; LATENT PERIOD; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REWARD;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ANIMALS; BICYCLO COMPOUNDS; BRAIN; DIHYDRO-BETA-ERYTHROIDINE; DOPAMINE ANTAGONISTS; ELECTRIC STIMULATION; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; MALE; NICOTINE; NICOTINIC AGONISTS; NICOTINIC ANTAGONISTS; PYRIDINES; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RECEPTORS, METABOTROPIC GLUTAMATE; RECEPTORS, NICOTINIC; REWARD; SALICYLAMIDES;

EID: 0036181180     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-001-0953-6     Document Type: Article

References (75)

1. 1 receptors in vivo
2. 1 agonist elevates self-stimulation thresholds: Comparison to other dopamine-selective drugs
3. In vivo inhibition of veratridine-evoked release of striatal excitatory amino acids by the group II metabotropic glutamate receptor agonist LY354740 in rats
4. Potentiation of lateral hypothalamic and midline mesencephalic brain stimulation reinforcement by nicotine: Examination of repeated treatment
5. Effects of dopamine D-1 and D-2 antagonists on cocaine self-administration under different schedules of reinforcement in the rat
6. Microinjections of phencyclidine (PCP) and related drugs into the nucleus accumbens shell potentiate medial forebrain bundle brain stimulation reward
7. Rewarding actions of phencyclidine and related drugs in nucleus accumbens shell and frontal cortex
8. 5 null mutant mice
9. Effects of nicotine and d-amphetamine on intracranial self-stimulation in a shuttle box test in rats
10. Autoradiographic evidence for nicotine receptors on nigrostriatal and mesolimbic dopaminergic neurons
11. Innervation of substantia nigra neurons by cholinergic afferents from pendunculopontine nucleus in the rat: Neuroanatomical and electrophysiological evidence
12. Pharmacology and functions of metabo-tropic glutamate receptors
13. Regulation of neuronal circuits and animal behavior by metabotropic glutamate receptors
14. Nicotine maintains robust self-administration in rats on a limited-access schedule
15. Selective dopamine antagonists reduce nicotine self-administration
16. The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine
17. Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area
18. Behavioural pharamcology and neurobiology of nicotine reward and dependence
19. Nicotine self-administration in rats
20. Nicotine self-administration in rats on a progressive ration schedule of reinforcement
21. Dramatic decreases in brain reward function during nicotine withdrawal
22. Systemic nicotine stimulates dopamine release in nucleus accumbens: Re-evaluation of the role of N-methyl-D-aspartate receptors in the ventral tegmental area
23. 5 receptor antagonist
24. Lateralization of reward in rats: Differences in reinforcing thresholds
25. An oral self-administration model of nicotine preference in rats: Effects of mecamylamine
26. Reinforcing effects of nicotine in humans and experimental animals responding under intermittent schedules of i.v. drug injection
27. Persistent behavior at high rates maintained by intravenous self-administration of nicotine
28. Evidence that nicotinic alpha (7) receptors are not involved in the hyperlocomotor and rewarding effects of nicotine
29. Fluoxetine combined with a serotonin-1A receptor antagonist reversed reward deficits observed during nicotine and amphetamine withdrawal in rats
30. Multiple determinants of dihydro-beta-erythroidine sensitivity on rat neuronal nicotinic receptor alpha subunits
31. LY354740: A metabotropic glutamate receptor agonist which ameliorates symptoms of nicotine withdrawal in rats
32. Nicotine as a reinforcer in human subjects and laboratory animals
33. The effect of MK 801 and other antagonists of NMDA-type glutamate receptors on brain-stimulation reward
34. Excitatory amino acid pathways in brain-stimulation reward
35. 2 agonists and antagonists on fixed-interval responding for brain stimulation
36. Effects of nicotine on the threshold for rewarding brain stimulation in rats
37. Nicotine and brain-stimulation reward: Interactions with morphine, amphetamine and pimozide
38. Nicotine-induced decreases in VTA self-stimulation thresholds: Blockade by haloperidol and mecamylamine but not scopolamine or ondansetron
39. Neurobiology of the nicotine withdrawal syndrome
40. 3H]eticlopride in the rat brain: Evidence for selective labelling of dopamine receptors
41. Euphorigenic drugs: Effects on the reward pathways of the brain
42. The effect of operant and electrode placement on self-stimulation train duration response functions
43. Construct validity of a self-stimulation threshold paradigm: Effects of reward and performance manipulations
44. Intracranial self-stimulation thresholds as a measure of reward
45. 7 nicotinic receptors in nicotine self-administration and nicotine withdrawal in the rat
46. Common neural substrates for the addictive properties of nicotine and cocaine
47. Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats
48. The effects of dopaminergic agonists and antagonists on the frequency-response function for hypothalamic self-stimulation in the rat
49. Effects of cholinergic agonists and antagonists on self-stimulation behavior in the rat
50. Systemic nicotine induced dopamine release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral tegmental area
51. Nicotine dependence, midbrain dopamine systems and psychiatric disorders
52. Comparison of muscarinic and nicotinic cholinergic agonists on self-stimulation behavior
53. Effects of methyllycaconitine (MLA), an alpha 7 nicotinic receptor antagonist, on nicotine- and cocaine-induced potentiation of brain stimulation reward
54. Effect of dose on cocaine self-administration and dopamine levels in the nucleus accumbens
55. 2 subunit are involved in the reinforcing properties of nicotine
56. Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs
57. Effects of nicotine on self-stimulation in rats
58. Nicotine stimulation of extracellular glutamate levels in the nucleus accumbens: Neuropharmacological characterization
59. A comparison of nicotine and cocaine self-administration in the dog: Fixed ratio and progressive ratio schedules of intravenous drug infusion
60. Extinction and recovery of cocaine self-administration following 6-hydroxydopamine lesions of the nucleus accumbens
61. 7 nicotinic receptors in the ventral tegmental area
62. N-methyl-D-aspartate receptor antagonism in the ventral tegmental area diminished the systemic nicotine-induced dopamine release in the nucleus accumbens
63. Putative role of presynaptic alpha7* nicotinic receptors in nicotine stimulated increases of extracellular levels of glutamate and aspartate in the ventral tegmental area
64. LY354740 is a potent and highly selective group II glutamate receptor agonist in cells expressing human glutamate receptors
65. 3H]acetylcholine on catecholamine and serotonin axons in brain
66. Role of excitatory amino acids in the ventral tegmental area for central actions of non-competitive NMDA-receptor antagonists and nicotine
67. Immunohistochemical localization of neuronal nicotinic receptors in the rodent central nervous system
68. Receptor systems participating in nicotine-specific effects
69. 2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: A hybridization histochemical study in the rat
70. Blockade of nicotine self-administration with nicotinic antagonists in rats
71. Reward and somatic changes during precipitated nicotine withdrawal in rats: Centrally and peripherally mediated effects
72. Brain dopamine and reward
73. Blockade of the reward-potentiating effects of nicotine on lateral hypothalamic brain stimulation by chlorisondamine
74. Both nicotinic and muscarinic receptors in ventral tegmental area contribute to brain-stimulation reward